Tuesday, January 17, 2012

Roche Refuses to Disclose Tamiflu Data: Scientists - Jan. 17, 2012

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Tuesday, January 17, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

PPD Central Labs

Combine the expertise of a leading contract research organization (CRO) with global central laboratories that are among the world's largest dedicated exclusively to clinical trials.

We offer:
• Comprehensive range of central lab services
• Extensive reach
• High level of accuracy

Please click here for more information.
HeadHtml
•  Roche (RHHBY) Refuses to Disclose Tamiflu Data: Scientists More...
•  Johnson & Johnson (JNJ) Marketed Rispersal for Children After FDA Warnings, Texas Jury Told More...
•  Galderma Laboratories Announces Availability of New Metrogel(R) 1% Pump Dispenser for the Treatment of Papulopustular Rosacea More...
More Drug Product News
HeadHtml
•  Seattle Genetics, Inc. (SGEN) Lymphoma Drug Gets Boxed Warning on Brain Infection Risk More...
More Discontinuations News
More Recalls and Warning News
HeadHtml
•  Pfizer Inc. (PFE) Ditches $725 Million Medivation, Inc. (MDVN) Pact as Phase 3 Alzheimer Trial Disappoints More...
•  ArQule, Inc. (ARQL) Says Tivantinib Meets Primary Endpoint; Stock Rises +1.33(22.38%) @ 1:17PM EST More...
•  VIVUS, Inc. (VVUS)'s REVIVE Trial Results for Avanafil Published in JSM Demonstrate Significant Improvement in Erectile Function More...
•  BrainStorm Cell Therapeutics Inc. Announces Clinical Data Supporting Safety and Efficacy of NurOwn(TM) Based on Initial Patient Results More...
•  Ventrus Biosciences, Inc.  (VTUS) Announces Publication of Prior Phase 2b Study on the Safety and Efficacy of Iferanserin in the Treatment of Hemorrhoid Disease More...
More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
Events

UC San Diego Extension: 2012 Medicinal Chemistry Intensive Program

Monday, March 12, 2012 to Friday, March 16, 2012
La Jolla Shores Hotel, 8110 Camino del Oro
La Jolla, California

This accelerated 1-week program focuses on the chemistry of drug molecules and drug action. Developed and taught by experienced pharmaceutical and biotechnology professionals, it covers topics essential for understanding the multidisciplinary areas of medicinal chemistry.

Program Objectives:

- To teach the essential and diverse principles of medicinal chemistry and modern drug discovery to chemists and biologists.

- To provide scientists the opportunity for career advancement in biotechnology and pharmaceutical companies.

For more information, please visit: http://extension.ucsd.edu/studyarea/index.cfm?vAction=singleCourse&vCourse=BIOL-40116.
Featured Free Resource

Quantifying the Value of Pipeline Pilot, the Accelrys Scientific Enterprise Platform

This white paper outlines the methodology, sources of value, and quantifiable results from bringing products to market faster, avoiding unproductive experiments, saving developer time, and more.

Request Now!
HeadHtml
•  Magnesium-Rich Diet Tied to Lower Stroke Risk, Karolinska Institute Study More...
•  Vitamin D Doesn't Ease Lung Disease Symptoms, University Hospitals Leuven Study More...
•  People Mimic Each Other, but Only When They Have the Same Goal, Radboud University Study More...
•  Vidacare Corporation Release: Study Finds Intraosseous Infusion is Equivalent to Intravenous Infusion During Therapeutic Hypothermia More...
•  AxoGen, Inc. (LECT) and Cockrell Group Release: Avance Pharma Inc. Nerve Graft Clinical Results Published More...
More General Clinical Research News
Latest Market Insight

Innovative Clinical Trial Design and Management

• Use detailed case studies of recent adaptive trials featuring companies including Merck, Pfizer, Novartis, GSK, Eli Lilly, and AstraZeneca.
• Measure the potential cost savings offered by the reduced development times and improved decision-making associated with adaptive trials
• Assess the logistics of adaptive trial implementations.

Click Here for More Information.
Tower: Facebook
Top Jobs
Genetown (Cambridge, Massachusetts)

Sanofi
Clinical Scientist
Contribute to (assist the clinical lead in) the clinical development plans for new compounds in collaboration with the project MD or project head, including review of the preclinical package

BioMidwest (Chicago, Illinois)

AVEO Pharmaceuticals, Inc.
Regional Senior Clinical Research Associate
Responsible for monitoring the progress of clinical oncology studies at investigative sites, and ensuring that clinical studies are conducted, recorded, and reported in accordance with the protocol, standard operating procedures (SOPs), ICH-GCP, and all applicable regulatory requirements.

Pharm Country (Wayne, Pennsylvania)

Octagon Research Solutions, Inc.
Clinical Programming Manager
Will provide leadership in the creation and validation of SAS programs in support of sponsors clinical trials; ensuring that the SOPs and guidelines are followed in creating the derived clinical databases and data displays to high quality and per agreed timelines.

BioCapital (Wilmington, Delaware)

AstraZeneca Pharmaceuticals LP
Director, Clinical Research
Provide medical expertise for Life Cycle Development and claims development. Responsible (in collaboration with other Team members) for medical components of the design, execution, and reporting of LCM study protocols as well as labelling and regulatory communications under the direction of the Medical Science Director.

Biotech Bay (Oakland, California)

Cerexa, Inc.
Clinical Operations Contractors
Manage all aspects of global clinical studies; including in-house study team management; CRO and 3rd party vendor management. Analyze/report safety/patient care/study design issues; develop/direct clinical monitoring/study management plans and direct study monitoring priorities

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


BioSpace Life Science Career Fairs are the biotech industry's premier career events. Featuring well-respected employers from around the nation, our job fairs attract top candidates in the biotech, pharmaceutical, life science and medical device industries.

With such a great number of recruiters and hiring managers from top biotech companies attending our career fairs, there are an abundance of opportunities available for job seekers. Many different disciplines within the industry are represented bringing a diversity of candidates to our job fairs.

Companies seeking pharmaceutical sales representatives and marketing jobs regularly attend our job fairs. Engineering and technical jobs can be found, as well as regulatory jobs and positions in QA/QC. Individuals desiring a science job or a research job will find many opportunities at our job fairs. In addition, hiring managers seeking candidates for clinical research jobs also attend our events.

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  Alnylam Pharmaceuticals (ALNY) Files Patent Infringement Suit Against Tekmira Pharmaceuticals Corporation More...
•  Seegene, Inc. Strengthens Position in Multiplex PCR With Award of United States Patent for Dual Priming Oligonucleotide (DPO(TM)) Technology More...
•  Apricus Biosciences (APRI) Announces Allowance of Israeli Patent, Expanding Its Patent Portfolio for the Topical Treatment of Premature Ejaculation More...
•  Hemispherx Biopharma (HEB) Receives U.S. Patent Office Notification of Two New Patents Granted for Alferon(R) LDO More...
•  Ampio Pharmaceuticals, Inc. (AMPE)' Zertane(TM) Patent Estate Bolstered by Two New European Patents More...
More Patent News
Feature

Hot Company

Gallus Biopharmaceuticals, LLC
4766 LaGuardia Drive
St. Louis, Missouri 63134 U.S.A.
Phone: 314-426-5000 Fax: 314-426-1792

Gallus Biopharmaceuticals, LLC has recently emerged on the market as a premier cGMP biologics contract manufacturing organization based in St. Louis, MO USA. Gallus operates an FDA-approved, commercial facility formerly owned by Centocor Biologics. The plant has been approved by every major regulatory agency and currently manufactures two of Centocor Biologics' leading products, Remicade® and Stelara(TM), which are distributed globally.

More Company Profiles
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: